[Bacterial translocation from the gastrointestinal tract: catalyst of multiple organ dysfunction syndrome]

Khirurgiia
|August 4, 2001
PubMed

Insights

Bacterial translocation (BT) contributes to multiple organ dysfunction syndrome (MODS) after surgery. Amikacin plus Clindamycin showed a good therapeutic effect for patients with MODS and sepsis.

Area of Science:

  • Gastroenterology
  • Critical Care Medicine
  • Infectious Diseases

Background:

  • Intestinal insufficiency, marked by abnormal gut microbiota, barrier dysfunction, and bacterial translocation (BT), is implicated in the pathogenesis of multiple organ dysfunction syndrome (MODS).
  • MODS significantly worsens patient outcomes, particularly in intensive care unit (ICU) patients following major abdominal surgery.

Purpose of the Study:

  • To review scientific and clinical evidence on the role of BT in MODS pathogenesis.
  • To evaluate the efficacy of Amikacin plus Clindamycin as a novel therapeutic strategy for improving outcomes in MODS and sepsis patients.

Main Methods:

  • Analysis of patients with diffuse peritonitis of various origins.
  • Patients were grouped based on antibiotic treatment: standard antibiotics versus Amikacin plus Clindamycin.
  • Microbiological analyses were performed on abdominal cavity samples from patients with laparostomy.

Main Results:

  • The Amikacin plus Clindamycin combination was well-tolerated by patients.
  • This antibiotic regimen demonstrated a good therapeutic effect in the subgroup of patients studied.

Conclusions:

  • Bacterial translocation plays a crucial role in the development of MODS.
  • Amikacin plus Clindamycin presents a promising therapeutic option for managing MODS and sepsis, improving patient outcomes.

Related Concept Videos

Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Intestinal Obstruction II: Pathophysiology01:07

Intestinal Obstruction II: Pathophysiology

Intestinal obstruction triggers a series of physiological responses, starting with gas and fluid accumulation in the bowel segment proximal to the obstruction, leading to distension. This distended intestine compresses the diaphragm, hindering lung expansion and potentially leading to reduced respiratory effort, atelectasis, and pneumonia.To overcome the blockage, the gut intensifies contractions, causing colicky abdominal pain, nausea, and vomiting, which reduces fluid and food intake and...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...